default author photo

Brad S. Kahl

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Improvements in Outcomes in Older Patients with Mantle Cell Lymphoma are Driven by Improvements Across Multiple Lines of Therapy

Number of pages: 24 Posted: 26 Oct 2024
Danny Luan, Neela Easwar, Zhengming Chen, Brian K. Link, Matthew J. Maurer, Brad S. Kahl, Laura Pinheiro, John Leonard and Peter Martin
Cornell University - Weill Cornell Medicine, affiliation not provided to SSRN, Cornell University - Weill Cornell Medicine, affiliation not provided to SSRN, Mayo Clinic, affiliation not provided to SSRN, Cornell University - Weill Cornell Medicine, Cornell University - Weill Cornell Medicine and Weill Cornell Medical Center - Lymphoma Service
Downloads 43 (1,145,425)

Abstract:

Loading...

Mantle cell lymphoma, SEER-Medicare, epidemiology, treatment trends

2.

A Phase I Study of Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone in Patients with Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas

Number of pages: 15 Posted: 20 Mar 2024
Nicole Foley, Peter A. Riedell, Nancy L. Bartlett, Amanda F. Cashen, Brad S. Kahl, Todd A. Fehniger, Anne Fischer, Chaz Moreno, Jingxia Liu, Kenneth R. Carson and Neha Mehta-Shah
affiliation not provided to SSRN, University of Chicago, affiliation not provided to SSRN, Washington University in St. Louis - Division of Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Washington University in St. Louis - School of Medicine, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 39 (1,196,171)

Abstract:

Loading...

T-cell lymphoma, histone deacetylase inhibitor, angioimmunoblastic T-cell lymphoma